Past preclinical trials for different therapeutic interventions conventionally did not Look at the effects from the tested intervention to SoC medications. In actual fact, little or no preclinical details exist for the antitumor efficacy of SoC drugs in preclinical patient-derived pediatric tumor versions. This is principally as a consequence of Th